Neurology Clinical Trials Market

The neurology clinical trials market involves the research and development of new drugs, therapies, and medical devices for treating conditions of the nervous system, such as Alzheimer's, Parkinson's, and epilepsy. The primary customers are pharmaceutical and biotechnology companies who conduct these trials. Key growth drivers include the increasing global prevalence of neurological disorders, growing R&D investments from both public and private sectors, and the urgent need for more effective treatments.